Godsey & Gibb Inc’s Edwards Lifesciences EW Stock Holding History

Godsey & Gibb Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-51	Closed	-$3.37K	–	387
2024 Q3	$3.37K	Buy	+51	New	+$3.71K	﹤0.01%	385

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Godsey & Gibb Inc's EW Position: Q4 2024 in Review

Godsey & Gibb Inc sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 51 shares — an estimated $3.37K sold.

Godsey & Gibb Inc first reported a position in EW in Q3 2024 and held it in 1 quarter. The position peaked at $3.37K in Q3 2024. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2024.

Godsey & Gibb Inc reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
Godsey & Gibb Inc sold 51 Edwards Lifesciences shares in Q4 2024, an estimated $3.37K.
Godsey & Gibb Inc first reported a position in Edwards Lifesciences in Q3 2024 and held it in 1 quarter.
Godsey & Gibb Inc's Edwards Lifesciences position peaked at $3.37K in Q3 2024.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Godsey & Gibb Inc's 13F filing for Q4 2024, filed 14 Jan 2025.